TRCE’s mission is to unlock the fundamental mechanisms central to an organ’s regenerative capacity and to develop novel therapeutics which can augment biological function.
Projects

Mechanisms of liver regeneration
We study a range of different tissues and organs but are particularly interested in the liver, as its capacity to regenerate is one of nature’s most remarkable phenomena. We still don’t fully understand how this unique organ senses a wide range of cell injuries and regenerates so quickly and precisely. Recent advances have shown that liver regeneration results in clonal expansions of liver cells, called hepatocytes. Some of these hepatocytes acquire mutations that improve their abilities to grow and survive. A major part of our research program is to model this clonal evolution, experimentally and computationally, in order to better understand the biological basis of the selection advantages which allow survival of the fittest hepatocytes. Our discoveries will advance fundamental knowledge of liver biology and help us identify potential targets for drug discovery. We will then be able to shape the evolutionary process, bio-engineer highly robust hepatocytes and treat liver diseases to address a rapidly increasing clinical need.
Publications
-
-
Large-scale genomic analysis of human iPSCs identifies recurrent somatic driver mutations
-
Convergent somatic mutations in metabolism genes in chronic liver disease
-
Outpatient ureteric stent removal following kidney transplantation
-
Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells
Awards
Medical Research Council Clinician Scientist Fellowship (2023)
Projects

Mechanisms of liver regeneration
We study a range of different tissues and organs but are particularly interested in the liver, as its capacity to regenerate is one of nature’s most remarkable phenomena. We still don’t fully understand how this unique organ senses a wide range of cell injuries and regenerates so quickly and precisely. Recent advances have shown that liver regeneration results in clonal expansions of liver cells, called hepatocytes. Some of these hepatocytes acquire mutations that improve their abilities to grow and survive. A major part of our research program is to model this clonal evolution, experimentally and computationally, in order to better understand the biological basis of the selection advantages which allow survival of the fittest hepatocytes. Our discoveries will advance fundamental knowledge of liver biology and help us identify potential targets for drug discovery. We will then be able to shape the evolutionary process, bio-engineer highly robust hepatocytes and treat liver diseases to address a rapidly increasing clinical need.
Publications
-
-
Large-scale genomic analysis of human iPSCs identifies recurrent somatic driver mutations
-
Convergent somatic mutations in metabolism genes in chronic liver disease
-
Outpatient ureteric stent removal following kidney transplantation
-
Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells
Awards
Medical Research Council Clinician Scientist Fellowship (2023)
Our Partners

The Francis Crick Institute